Clinical Trial Update: AE-941 in Treating Patients With Metastatic Kidney Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial of Neovastat (AE-941) for metastatic kidney cancer has completed. The update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Neovastat (AE-941)

Snippet

Sponsor: AEterna Zentaris | Conditions: Kidney Cancer | Phase 3 | Status: COMPLETED